Author Archives:

Delaware joins real-world evidence collaboration

Posted on February 23, 2012

In 2011, 207,000 Delawareans received their health coverage through Medicaid. This population is expected to grow by 25,000 beneficiaries when Medicaid eligibility expands in 2014. Like many other states, Delaware is focused on finding new ways to improve quality and … Continue reading →

Posted in Uncategorized | Leave a comment

More patients eligible for free AstraZeneca medicines

Posted on February 8, 2012

AstraZeneca has broadened the income eligibility for our AZ&Me™ Prescription Savings Programs so that more patients may qualify to receive free medicines. AZ&Me program director Jennifer McGovern explained that the reason for the change was “to keep pace with the … Continue reading →

Posted in Patient Assistance | 1 Comment

AstraZeneca recognized for engagement through social media

Posted on February 6, 2012

How are healthcare organizations using social media to engage their stakeholders in conversations about those issues most important to them? Creation Healthcare’s 2012 Healthcare Engagement Strategy awards show how organizations are using a variety of social media tools to build … Continue reading →

Posted in Social Media | 4 Comments

Building blocks for healthier youth

Posted on January 25, 2012

The AstraZeneca Young Health Program, IM40, is designed to give adolescents the tools they need to be healthier and to live up to their potential in school and in life. At the heart of this program is a set of … Continue reading →

Posted in Young Health Program

AmeriCares delivers donated AstraZeneca medicines to clinics

Posted on January 24, 2012

Today, AmeriCares announced that it has begun delivering several million dollars worth of donated AstraZeneca medicines to help patients who rely on safety net clinics for their medical care. AmeriCares is a nonprofit global health and disaster relief organization which … Continue reading →

Posted in Patient Assistance | 1 Comment

AstraZeneca Young Health Program aims to build up youth

Posted on January 20, 2012

AstraZeneca and United Way of Delaware kicked off a five-year initiative today to help youth ages 12-15 build up the inventory of personal and community assets they need to be healthier and more successful in school. This is part of … Continue reading →

Posted in Young Health Program | 1 Comment

Expanding our real-world evidence capabilities

Posted on January 11, 2012

Today, AstraZeneca announced an important milestone in our company’s work to build industry-leading real-world evidence capabilities around the world. Through a new three-year collaboration agreement with IMS Health, we will be advancing the use of real-world evidence that is based … Continue reading →

Posted in Real-world evidence

Real-World Evidence: Some key learnings from 2011

Posted on January 4, 2012

In her article in the December issue of IN VIVO, “Pharma/Payor Deals An Important Step In The Shift To Value-Based R&D,” Ellen Licking examines the opportunities and challenges brought by a new generation of business relationships between pharmaceutical companies and … Continue reading →

Posted in Real-world evidence

Real world challenges to communicating real-world evidence

Posted on December 12, 2011

Real-world evidence data offers new opportunities to discuss how to improve patient health and manage the total cost of care Our recent series of blog posts examining the use of real-world evidence generated a great deal of interest and discussion … Continue reading →

Posted in Real-world evidence

Real-world evidence: HealthCore’s journey

Posted on November 7, 2011

As part of an ongoing series, we are taking a look at how evidence can help us identify the health and cost impact of treatments on patients, while also highlighting areas of unmet patient needs. Earlier posts can be found here, here, here and … Continue reading →

Posted in Real-world evidence